AU3667100A - Composition for enhancing functional recovery of a mammal from central and/or peripheral nervous system injury of traumatic or pathological origin - Google Patents

Composition for enhancing functional recovery of a mammal from central and/or peripheral nervous system injury of traumatic or pathological origin

Info

Publication number
AU3667100A
AU3667100A AU36671/00A AU3667100A AU3667100A AU 3667100 A AU3667100 A AU 3667100A AU 36671/00 A AU36671/00 A AU 36671/00A AU 3667100 A AU3667100 A AU 3667100A AU 3667100 A AU3667100 A AU 3667100A
Authority
AU
Australia
Prior art keywords
traumatic
mammal
central
composition
nervous system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU36671/00A
Inventor
Sonia Arnaud
Pedro Bittmann
Diego Braguglia
Sophie Feldblum
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zimmer GmbH
Original Assignee
Zimmer GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zimmer GmbH filed Critical Zimmer GmbH
Publication of AU3667100A publication Critical patent/AU3667100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU36671/00A 1999-04-23 2000-04-19 Composition for enhancing functional recovery of a mammal from central and/or peripheral nervous system injury of traumatic or pathological origin Abandoned AU3667100A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13074199P 1999-04-23 1999-04-23
US60130741 1999-04-23
PCT/IB2000/000480 WO2000064460A2 (en) 1999-04-23 2000-04-19 Composition for enhancing functional recovery of a mammal from central and/or peripheral nervous system injury of traumatic or pathological origin

Publications (1)

Publication Number Publication Date
AU3667100A true AU3667100A (en) 2000-11-10

Family

ID=22446103

Family Applications (1)

Application Number Title Priority Date Filing Date
AU36671/00A Abandoned AU3667100A (en) 1999-04-23 2000-04-19 Composition for enhancing functional recovery of a mammal from central and/or peripheral nervous system injury of traumatic or pathological origin

Country Status (2)

Country Link
AU (1) AU3667100A (en)
WO (1) WO2000064460A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA006655B1 (en) * 2001-05-17 2006-02-24 Апплайд Резеч Системз Арс Холдинг Н.В. Use of osteopontin for the treatment and/or prevention of neurologic diseases
FI117667B (en) 2001-07-05 2007-01-15 Univ Zuerich A pharmaceutical composition suitable for use in orthopedics and dentistry
GB0207829D0 (en) * 2002-04-04 2002-05-15 Isis Innovations Ltd Stimulation of nerve cell regeneration

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0575555T3 (en) * 1991-03-11 2001-11-05 Curis Inc Protein-induced morphogenesis
US5290763A (en) * 1991-04-22 1994-03-01 Intermedics Orthopedics/Denver, Inc. Osteoinductive protein mixtures and purification processes
WO1994005791A2 (en) * 1992-09-03 1994-03-17 Regeneron Pharmaceuticals, Inc. Dorsal tissue affecting factor and compositions
ES2265146T3 (en) * 1993-08-26 2007-02-01 Genetics Institute, Llc HUMAN OSEAS MORPHOGENETIC PROTEINS FOR USE IN NERVOUS REGENERATION.
ES2214743T3 (en) * 1997-09-19 2004-09-16 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh COMBINATION OF CITOCINES WITH NEUROTROPHIC ACTIVITY.

Also Published As

Publication number Publication date
WO2000064460A2 (en) 2000-11-02
WO2000064460A3 (en) 2001-02-08

Similar Documents

Publication Publication Date Title
EP1208227A1 (en) Methods for diagnosing, preventing and treating developmental disorders due to a combination of genetic and environmental factors
AU5763900A (en) Methods of enriching for and identifying polymorphisms
IL129083A0 (en) Methods and compounds for inhibiting beta-amyloid peptide release and/or its synthesis
AU4710199A (en) Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
AU4995999A (en) Treatment for schizophrenia and other dopamine system dysfunctions
AU4078997A (en) Cholinesterase inhibitors for treatment of parkinson's disease
AU4707999A (en) Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
IL146529A0 (en) Method of inhibiting neurotrophin-receptor binding
IL146530A0 (en) Method of inhibiting neurotrophin-receptor binding
AU3224800A (en) Chip removal and replacement system
AU5204799A (en) Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
EP1235785A4 (en) Novel compounds to treat diabetes and associated conditions
AUPO376296A0 (en) Removal of silica from bauxite
AU1742200A (en) Prevention and treatment of amyloid-associated disorders
AU4477700A (en) Licensed band adaptations
AU1569501A (en) Beta-aminoacid compounds useful for inhibiting beta-amyloid peptide release and/or its synthesis
AU1830700A (en) Quick release and fastening cover
AU5690998A (en) Use of alpha-conotoxin mii to treat disorders resulting from nicotine-stimulated dopamine release
AU3667100A (en) Composition for enhancing functional recovery of a mammal from central and/or peripheral nervous system injury of traumatic or pathological origin
AU1338801A (en) Methods of protecting neuronal function
AU2432001A (en) Treatment of mental conditions including depression
AUPQ456299A0 (en) Recovery of precious metals
GB9828798D0 (en) Automatic mounting/dismounting of mage display devices
EP1025103A4 (en) Novel polymorphic forms of cipamfylline
EP1032400A4 (en) Prevention of precipitated acute urinary retention

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase